- €50.23m
- €30.36m
- €53.41m
- 99
- 72
- 42
- 87
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.37 | ||
| Price to Tang. Book | 1.37 | ||
| Price to Free Cashflow | 6.32 | ||
| Price to Sales | 0.97 | ||
| EV to EBITDA | 3.56 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9.05% | ||
| Return on Equity | 6.64% | ||
| Operating Margin | 7.39% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 32.38 | 63.1 | 85.92 | 60.9 | 53.41 | n/a | n/a | 13.52% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +53.35 | +157.23 | +22.36 | -44.07 | -63.04 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
DocCheck AG is a Germany-based Company. The Company is engaged in the healthcare sector. The are three main business areas: agency business, access business and retail business. The agency business develops and implements communication concepts for the healthcare and B2B market. The access business helps to grow community for medical professionals. It also includes online advertising, online market research, online studies. The retail business provides medical supplies and medical technology.
Directors
- Joachim Pietzko CSU
- Frank Antwerpes CEO
- Britta Boeckmann VSU
- Philip Stadtmann CFO
- Thilo Koelzer COO
- Jens Knoop CTO
- Winfried Leimeister SUB
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- November 9th, 1999
- Public Since
- November 4th, 2011
- No. of Employees
- 433
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
XETRA- Shares in Issue
- 5,073,816
- Address
- Vogelsanger Str. 66, KOELN, 50823
- Web
- https://www.doccheck.ag/
- Phone
- +49 22192053100
- Auditors
- EBNER STOLZ GMBH & CO. KG WIRTSCHAFTSPRUFUNGSGESELLSCHAFT ST
Upcoming Events for AJ91
Dividend For ANWGn.DE - 0.7500 EUR
DocCheck AG Annual Shareholders Meeting
Similar to AJ91
FamiCord AG
XETRA
M1 Kliniken AG
XETRA
FAQ
What is the Doccheck AG share price?
As of Today at 20:17 UTC, shares in Doccheck AG are trading at €9.90. This share price information is delayed by 15 minutes.
How has the Doccheck AG share price performed this year?
Shares in Doccheck AG last closed at €9.90 and the price had moved by +10% over the past 365 days. In terms of relative price strength the Doccheck AG share price has outperformed the FTSE Global All Cap Index by +7.25% over the past year.
What are the analyst and broker recommendations for Doccheck AG?
There is no consensus recommendation for this security.
Find out moreWhat is the Doccheck AG dividend yield?
The Doccheck AG dividend yield is 5.05% based on the trailing twelve month period.
Does Doccheck AG pay a dividend?
Last year, Doccheck AG paid a total dividend of €0.50, and it currently has a trailing dividend yield of 5.05%.Looking ahead, shares in Doccheck AG are due to go ex-dividend on 2025-05-29 and the next dividend pay date is 2025-06-02.
When does Doccheck AG next pay dividends?
Doccheck AG are due to go ex-dividend on 2025-05-29 and the next dividend pay date is 2025-06-02. The historic dividend yield on Doccheck AG shares is currently 5.05%.
How do I buy Doccheck AG shares?
To buy shares in Doccheck AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Doccheck AG?
As of the previous close price of €9.90, shares in Doccheck AG had a market capitalisation of €50.23m.
Where are Doccheck AG shares listed?
Here are the trading details for Doccheck AG:
- Country of listing: Germany
- Exchange: GER
- Ticker Symbol: AJ91
What kind of share is Doccheck AG?
Based on an overall assessment of its quality, value and momentum Doccheck AG is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Doccheck AG share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Doccheck AG share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Doccheck AG. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +11.72%.
As of the last closing price of €9.90, shares in Doccheck AG were trading +14.03% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Doccheck AG PE Ratio?
The Doccheck AG PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €9.90.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Doccheck AG?
Doccheck AG's management team is headed by:
- Joachim Pietzko - CSU
- Frank Antwerpes - CEO
- Britta Boeckmann - VSU
- Philip Stadtmann - CFO
- Thilo Koelzer - COO
- Jens Knoop - CTO
- Winfried Leimeister - SUB